NCT07702968

Brief Summary

This study evaluates the accuracy and feasibility of a portable low-field MRI (Hyperfine) device in patients presenting to the emergency department with suspected acute stroke. All enrolled patients undergo standard clinical imaging (CT, CT angiography, CT perfusion) and additionally receive a low-field MRI scan. Low-field MRI findings are compared to routine CT imaging and final clinical diagnosis. The study aims to determine whether low-field MRI can reliably detect acute ischemic stroke (including lacunar and large vessel occlusion), hemorrhagic stroke, and stroke mimics in the acute setting. Secondary outcomes include feasibility measures such as scan time, completion rate, patient satisfaction, and adverse events.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
13mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Apr 2026Aug 2027

Study Start

First participant enrolled

April 20, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 3, 2026

Last Update Submit

July 14, 2026

Conditions

Keywords

Acute strokeLow-field MRIHyperfine

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of low-field MRI for acute stroke detection

    Sensitivity, specificity, positive predictive value, and negative predictive value of low-field MRI findings for detecting acute stroke (ischemic or hemorrhagic) and stroke mimics, using final clinical diagnosis at discharge as the reference standard. Low-field MRI images are assessed by a neuroradiologist blinded to CT findings and final diagnosis.

    At time of low-field MRI scan (within 12 hours of symptom onset)

Secondary Outcomes (2)

  • Adverse events during low-field MRI scanning

    During low-field MRI scan and up to 30 minutes thereafter

  • Patient satisfaction with low-field MRI procedure

    Within 24 hours after low-field MRI scan.

Study Arms (4)

Ischemic stroke - lacunar infarct

Patients with clinical and radiological suspicion of lacunar ischemic stroke (subcortical infarct). These patients often receive additional conventional MRI during routine work-up for radiological confirmation. All patients undergo low-field MRI scanning in addition to routine clinical imaging.

Device: Low-field MRI

Hemorrhagic stroke

Patients with hemorrhagic stroke (intracerebral hemorrhage) demonstrated on non-contrast CT at the emergency department. All patients undergo low-field MRI scanning in addition to routine clinical imaging.

Device: Low-field MRI

Stroke mimic

Patients with non-stroke diagnosis based on clinical judgment and neuro-imaging at the emergency department (e.g., epilepsy, migraine, functional neurological disorder). All patients undergo low-field MRI scanning in addition to routine clinical imaging.

Device: Low-field MRI

Ischemic stroke - proximal vessel occlusion

Patients with ischemic stroke due to proximal vessel occlusion in the anterior circulation (large vessel occlusion, LVO) diagnosed by CT angiography at the emergency department. All patients in this group undergo low-field MRI scanning in addition to routine clinical imaging.

Device: Low-field MRI

Interventions

Low-field MRI (Hyperfine Swoop, 0.064 Tesla) is performed once, in addition to routine clinical imaging (non-contrast CT, CT angiography, and CT perfusion as clinically indicated). The scan is acquired after routine imaging and after initial treatment decisions, during office hours, with the patient on their ED bed. Scan duration and any interruptions are recorded.

Hemorrhagic strokeIschemic stroke - lacunar infarctIschemic stroke - proximal vessel occlusionStroke mimic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients presenting to the emergency department of a tertiary academic hospital (LUMC) with suspected acute stroke (stroke code activation) within 12 hours of symptom onset. The study population includes patients with ischemic stroke (large vessel occlusion and lacunar), hemorrhagic stroke, and stroke mimics, reflecting real-world acute stroke diagnostics.

You may qualify if:

  • Age ≥ 18 years
  • Presentation with suspected acute stroke (stroke code activation by ambulance paramedics)
  • Symptom onset \< 12 hours prior to presentation
  • Admission to the emergency department of the Leiden University Medical Center (LUMC) during office hours
  • Undergoing standard-of-care head CT imaging at the emergency department
  • Ability to provide informed consent (written or verbal in the acute setting, with deferred written consent if applicable)

You may not qualify if:

  • Imminent death
  • Severe claustrophobia preventing MRI
  • Presence of MRI-incompatible implanted devices (e.g., pacemaker, cochlear implant, insulin pump)
  • Known intra-ocular metallic foreign body or intracranial metallic clip/device identified on admission CT
  • Pregnancy
  • Acute life-threatening or disabling condition requiring immediate intervention that precludes study procedures
  • Any study-related delay that could interfere with time-critical stroke treatments (intravenous thrombolysis or endovascular thrombectomy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Center

Leiden, South Holland, 2333ZA, Netherlands

RECRUITING

Related Publications (2)

  • Mazurek MH, Cahn BA, Yuen MM, Prabhat AM, Chavva IR, Shah JT, Crawford AL, Welch EB, Rothberg J, Sacolick L, Poole M, Wira C, Matouk CC, Ward A, Timario N, Leasure A, Beekman R, Peng TJ, Witsch J, Antonios JP, Falcone GJ, Gobeske KT, Petersen N, Schindler J, Sansing L, Gilmore EJ, Hwang DY, Kim JA, Malhotra A, Sze G, Rosen MS, Kimberly WT, Sheth KN. Portable, bedside, low-field magnetic resonance imaging for evaluation of intracerebral hemorrhage. Nat Commun. 2021 Aug 25;12(1):5119. doi: 10.1038/s41467-021-25441-6.

    PMID: 34433813BACKGROUND
  • Sheth KN, Mazurek MH, Yuen MM, Cahn BA, Shah JT, Ward A, Kim JA, Gilmore EJ, Falcone GJ, Petersen N, Gobeske KT, Kaddouh F, Hwang DY, Schindler J, Sansing L, Matouk C, Rothberg J, Sze G, Siner J, Rosen MS, Spudich S, Kimberly WT. Assessment of Brain Injury Using Portable, Low-Field Magnetic Resonance Imaging at the Bedside of Critically Ill Patients. JAMA Neurol. 2020 Sep 8;78(1):41-7. doi: 10.1001/jamaneurol.2020.3263. Online ahead of print.

    PMID: 32897296BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Nyika Kruyt, MD, PhD

CONTACT

Robert Croese

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurologist

Study Record Dates

First Submitted

July 3, 2026

First Posted

July 14, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Due to the limited sample size, the single-centre design, and privacy considerations under GDPR, there is no plan to share individual participant data. Aggregate results will be published in peer-reviewed journals and presented at scientific meetings.

Locations